Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Pruritus Drugs Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Topical
  • 1.4.3 Oral
  • 1.4.4 Parenteral
• 1.5 Market by Application
  • 1.5.1 Global Pruritus Drugs Market Share by Application (2019-2025)
  • 1.5.2 Hematologic Pruritus
  • 1.5.3 Oncological Pruritus
  • 1.5.4 Renal Pruritus
  • 1.5.5 Endocrine Pruritus
  • 1.5.6 Cholestatic Pruritus
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Pruritus Drugs Market Size
• 2.2 Pruritus Drugs Growth Trends by Regions
  • 2.2.1 Pruritus Drugs Market Size by Regions (2019-2025)
  • 2.2.2 Pruritus Drugs Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players

• 3.1 Pruritus Drugs Market Size by by Players
  • 3.1.1 Global Pruritus Drugs Revenue by by Players (2014-2019)
  • 3.1.2 Global Pruritus Drugs Revenue Market Share by by Players (2014-2019)
  • 3.1.3 Global Pruritus Drugs Market Concentration Ratio (CR5 and HHI)
• 3.2 Pruritus Drugs Key Players Head office and Area Served
• 3.3 Key Players Pruritus Drugs Product/Solution/Service
• 3.4 Date of Enter into Pruritus Drugs Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Pruritus Drugs Market Size by Type (2014-2019)
• 4.2 Global Pruritus Drugs Market Size by Application (2014-2019)

5 North America

• 5.1 North America Pruritus Drugs Market Size (2014-2019)
• 5.2 Pruritus Drugs Key Players in North America
• 5.3 North America Pruritus Drugs Market Size by Type
• 5.4 North America Pruritus Drugs Market Size by Application

6 Europe

• 6.1 Europe Pruritus Drugs Market Size (2014-2019)
• 6.2 Pruritus Drugs Key Players in Europe
• 6.3 Europe Pruritus Drugs Market Size by Type
• 6.4 Europe Pruritus Drugs Market Size by Application

7 China

• 7.1 China Pruritus Drugs Market Size (2014-2019)
• 7.2 Pruritus Drugs Key Players in China
• 7.3 China Pruritus Drugs Market Size by Type
• 7.4 China Pruritus Drugs Market Size by Application

8 Japan

• 8.1 Japan Pruritus Drugs Market Size (2014-2019)
• 8.2 Pruritus Drugs Key Players in Japan
• 8.3 Japan Pruritus Drugs Market Size by Type
• 8.4 Japan Pruritus Drugs Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Pruritus Drugs Market Size (2014-2019)
• 9.2 Pruritus Drugs Key Players in Southeast Asia
• 9.3 Southeast Asia Pruritus Drugs Market Size by Type
• 9.4 Southeast Asia Pruritus Drugs Market Size by Application

10 India

• 10.1 India Pruritus Drugs Market Size (2014-2019)
• 10.2 Pruritus Drugs Key Players in India
• 10.3 India Pruritus Drugs Market Size by Type
• 10.4 India Pruritus Drugs Market Size by Application

11 Central & South America

• 11.1 Central & South America Pruritus Drugs Market Size (2014-2019)
• 11.2 Pruritus Drugs Key Players in Central & South America
• 11.3 Central & South America Pruritus Drugs Market Size by Type
• 11.4 Central & South America Pruritus Drugs Market Size by Application

12 International Players Profiles

• 12.1 Allergan Plc
  • 12.1.1 Allergan Plc Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Pruritus Drugs Introduction
  • 12.1.4 Allergan Plc Revenue in Pruritus Drugs Business (2014-2019))
  • 12.1.5 Allergan Plc Recent Development
• 12.2 Astellas Pharma Inc.
  • 12.2.1 Astellas Pharma Inc. Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Pruritus Drugs Introduction
  • 12.2.4 Astellas Pharma Inc. Revenue in Pruritus Drugs Business (2014-2019)
  • 12.2.5 Astellas Pharma Inc. Recent Development
• 12.3 GlaxoSmithKline Plc
  • 12.3.1 GlaxoSmithKline Plc Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Pruritus Drugs Introduction
  • 12.3.4 GlaxoSmithKline Plc Revenue in Pruritus Drugs Business (2014-2019)
  • 12.3.5 GlaxoSmithKline Plc Recent Development
• 12.4 Pfizer Inc.
  • 12.4.1 Pfizer Inc. Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Pruritus Drugs Introduction
  • 12.4.4 Pfizer Inc. Revenue in Pruritus Drugs Business (2014-2019)
  • 12.4.5 Pfizer Inc. Recent Development
• 12.5 Sanofi
  • 12.5.1 Sanofi Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Pruritus Drugs Introduction
  • 12.5.4 Sanofi Revenue in Pruritus Drugs Business (2014-2019)
  • 12.5.5 Sanofi Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Product (2019-2025)
• 13.2 Market Size Forecast by Application (2019-2025)
• 13.3 Market Size Forecast by Regions
• 13.4 North America
• 13.5 Europe
• 13.6 China
• 13.7 Japan
• 13.8 Southeast Asia
• 13.9 India
• 13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Transdermal drug delivery systems are the most preferred methods of delivering pruritus drugs.
The majority of the pruritus drugs are available in semi-solid topical dosage forms, such as lotions, gels, and creams, which are easier to apply, are less painful, and provides faster action than other forms of drug delivery methods. Moreover, transdermal drug delivery systems increase the bioavailability of active ingredients and prevent destructive hepatic first-pass metabolism. However, the delivery of small and lipophilic drugs is difficult through the method of drug development.
In 2018, the global Pruritus Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Pruritus Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pruritus Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Allergan Plc
Astellas Pharma Inc.
GlaxoSmithKline Plc
Pfizer Inc.
Sanofi
...

Market segment by Type, the product can be split into
Topical
Oral
Parenteral

Market segment by Application, split into
Hematologic Pruritus
Oncological Pruritus
Renal Pruritus
Endocrine Pruritus
Cholestatic Pruritus

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Pruritus Drugs status, future forecast, growth opportunity, key market and key players.
To present the Pruritus Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Pruritus Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.